Crossmark

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

Crossref DOI link: https://doi.org/10.1016/j.pharep.2018.05.008

Published Print: 2018-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dolati, Sanam

Ahmadi, Majid

Aghebti-Maleki, Leili

Nikmaram, Abbas

Marofi, Faroogh https://orcid.org/0000-0002-8110-7808
Rikhtegar, Reza

Ayromlou, Hormoz

Yousefi, Mehdi
License Information

Text and Data Mining valid from 2018-12-01
More Information

This article is maintained by: Elsevier

Article Title: Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2018.05.008

Content Type: article

Copyright: © 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.